Does dementia increase risk of thrombolysis?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurology

• Publication date

  2011-03-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e3182190d37PMID 21451151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous tissue plasminogen activator and stroke in the elderly.

  2010cited by this paper
• Is Thrombolysis Safe in the Elderly?: Analysis of a National Database

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.

  2009cited by this paper
• The response to IV rt‐PA in very old stroke patients

  2008cited by this paper
• Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Prevalence and risk factors of cerebral microbleeds

  2008cited by this paper
• Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.

  2007cited by this paper
• Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004.

  2007cited by this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cited by this paper
• Clinical interpretation and use of stroke scales.

  2006cited by this paper
• Cerebral microbleeds on MRI

  2006cited by this paper
• Mortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatient sample

  2006cited by this paper
• Clinical importance of microbleeds in patients receiving IV thrombolysis

  2005cited by this paper
• Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

  2004cited by this paper
• Predictors of Severe Stroke: Influence of Preexisting Dementia and Cardiac Disorders

  2002cited by this paper
• Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

  2000cited by this paper
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

  1999cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

  1999cited by this paper
• Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

  1999cited by this paper
• Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Risk factors for primary cerebral hemorrhage: a population-based study--the Stroke Registry of Dijon.

  1995cited by this paper
• Statistics notes: Matching

  1994cited by this paper
• A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke.

  1988cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Impact of Dementia on Outcomes in Patients with Acute Ischemic Stroke: A Cross-Sectional Study of 420,375 Hospitalizations.

  2025cites this paper
• Preexisting dementia is not independently associated with short-term functional outcomes in acute anterior ischemic stroke with atrial fibrillation on oral anticoagulant therapy: a sub-analysis of the prospective analysis of stroke patients taking oral anticoagulants (PASTA) study results.

  2025cites this paper
• Colonoscopy Utilization in Elderly Patients with Dementia: Characteristics, Complications, and Charges in a National Matched-Cohort Analysis

  2024cites this paper
• Thrombolysis Outcomes in Acute Ischaemic Stroke Patients with Pre-Existing Cognitive Impairment

  2023influential citation
• Reperfusion therapies for ischemic stroke in dementia and cognitive impairment: A systematic review and meta-analysis

  2023cites this paper
• Dementia and acute care of ischemic stroke in Japan: A retrospective observational study using the Japanese Diagnosis Procedure Combination database

  2023cites this paper
• Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients With Premorbid Disability or Dementia: A Scientific Statement From the American Heart Association/American Stroke Association

  2022cites this paper
• Mechanical Thrombectomy for Acute Ischemic Stroke in Patients With Dementia

  2022cites this paper
• Imperfect Patients: Disparities in Treatment of Stroke Patients with Premorbid Disability

  2022cites this paper
• RP11-362K2.2:RP11-767I20.1 Genetic Variation Is Associated with Post-Reperfusion Therapy Parenchymal Hematoma. A GWAS Meta-Analysis

  2021influential citation
• Pre-stroke cognitive impairment in acute ischemic stroke patients predicts poor functional outcome after mechanical thrombectomy

  2021cites this paper
• Management of Vascular Risk Factors in Dementia

  2021cites this paper
• Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee

  2021cites this paper
• Endovascular Therapy or Alteplase in Patients with Comorbidities: Insights from UNMASK EVT

  2020cites this paper
• Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment

  2018cites this paper
• Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability

  2018cites this paper
• Acute Stroke Care in Dementia: A Cohort Study from the Swedish Dementia and Stroke Registries

  2018cites this paper
• Management of acute ischaemic stroke in patients with dementia

  2017cites this paper
• Thrombolysis in acute ischemic stroke in patients with dementia

  2017cites this paper
• Factors that influence variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke: results of a discrete choice experiment

  2017cites this paper
• Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries.

  2017cites this paper
• Comorbidity and dementia: a mixed-method study on improving health care for people with dementia (CoDem)

  2016cites this paper
• Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2016cites this paper
• Thrombolysis in dementia patients with acute stroke: is it justified?

  2016cites this paper
• Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke

  2016cites this paper
• AHA elegibility for thrombolysis

  2016cites this paper
• Stroke occurring in patients with cognitive impairment or dementia

  2016cites this paper
• Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke

  2015cites this paper
• Nouvelles limites de la thrombolyse intraveineuse dans le traitement des infarctus cérébraux

  2015cites this paper
• [Cardiac manifestations of mitochondrial diseases].

  2015cites this paper
• [An update on limitations of intravenous thrombolysis to treat acute ischemic stroke].

  2015cites this paper
• Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications

  2014cites this paper
• Thrombolytic therapy for stroke in patients with preexisting cognitive impairment

  2014cites this paper
• The complexities of acute stroke decision-making: A survey of neurologists

  2014cites this paper
• Influence of cognitive impairment on the management of ischaemic stroke.

  2014cites this paper
• Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?

  2013cites this paper
• Writ e Click: Editor ’ s Choice

  2013cites this paper
• The complexities of acute stroke decision-making

  2013cites this paper
• The exact science of stroke thrombolysis and the quiet art of patient selection.

  2013cites this paper
• Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis

  2012cites this paper
• How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials

  2012cites this paper
• rt-PA for ischaemic stroke: what will the next question be?

  2012cites this paper
• Advances in Epilepsy Management and Current Perspectives

  year unknowncites this paper
• Colonoscopy Utilization in Elderly Dementia Patients: Characteristics, Complications, and Charges in a National Matched-Cohort Analysis

  year unknowncites this paper